TABLE 3.
List of Adverse Ocular Events in the Study Eye in the Safety Population (N=31), Where n>1
| Adverse Event | n (%) |
|---|---|
| Intraocular pressure increased | 15 (48.4) |
| Visual acuity reduced | 9 (29.0) |
| Vision blurred | 7 (22.6) |
| Hyphema | 7 (22.6) |
| Visual field defect | 6 (19.4) |
| Dry eye | 6 (19.4) |
| Pupillary deformity | 4 (12.9) |
| Vital dye staining cornea present | 3 (9.7) |
| Conjunctival hemorrhage | 3 (9.7) |
| Conjunctival hyperemia | 3 (9.7) |
| Corneal edema | 3 (9.7) |
| Eye pain | 3 (9.7) |
| Photophobia | 3 (9.7) |
| Postprocedural hemorrhage | 2 (6.5) |
| Intraocular pressure decreased | 2 (6.5) |
| Anterior chamber disorder | 2 (6.5) |
| Chorioretinal folds | 2 (6.5) |
| Conjunctivochalasis | 2 (6.5) |
| Ocular discomfort | 2 (6.5) |
| Conjunctivitis | 2 (6.5) |